Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-28

Clinical Trial Update: Flomax Study for Floppy Iris Syndrome

View source ↗

Summary

The document reports that the Flomax (tamsulosin) study for floppy iris syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flomax (tamsulosin hydrochloride)

Snippet

Sponsor: University of Michigan | Conditions: Floppy Iris Syndrome | Status: COMPLETED